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Background: The age of onset of vitiligo is before 20 years in approximately in 50% of patients, and its
incidence decreases with increasing age. In this study, our aim was to analyze the epidemiological and
clinical factors of patients with late-onset vitiligo and compare these to patients with early-onset vitiligo.
Methods: Eight hundred and twenty-ﬁve consecutive patients with vitiligo were examined from March
2003 through May 2006. The patients were divided into late-onset (disease onset > 50 years of age) and
early-onset groups.
Results: There were 54 (6.5%) patients diagnosed with late-onset vitiligo; 48.1% of these patients were
female. Of those with early-onset vitiligo, 63.9% were female and 36.1% were male (p¼ 0.02). Positive
family history was present in 27.8% and 40.4% of the late- and early-onset groups, respectively. The most
common ﬁrst sites of involvement were the limbs in both groups. Generalized vitiligo (vitiligo vulgaris)
was the most common presentation in both groups. Koebner phenomenon was detected in 79.6% of late-
and 64.9% of early-onset vitiligo patients (p¼ 0.02). Leukotrichia was present in 77.8% of late- and 52.7%
of patients with early-onset vitiligo (p< 0.001). Mucosal involvement was observed in 59.3% and 47% of
late- and early-onset vitiligo patients, respectively (p¼ 0.08). Associated diseases were seen in 18.5% of
late- and in 23.1% of early-onset vitiligo patients.
Conclusion: In patients with late-onset vitiligo, male gender, Koebner phenomenon, leukotrichia, and
mucosal involvement were more common than in patients with early-onset vitiligo.
Copyright  2012, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Vitiligo is an acquired depigmentation disease that affects 1e2% of
the general population without any racial, sexual, or regional pre-
dominances.1e6 It is characterized by white macules, patches of
skin, and hair that result from the selective loss of melanocytes.
Although vitiligo is generally considered a cosmetic problem, its
effect on the psychosocial well-being of patients should not be
neglected.7,8 There are four main patterns of presentation including
common generalized, localized, acrofacial, and segmental.9 The
etiology of this disease is still unknown; however, autoimmune and
neurogenic factors have been implicated. Self-destruction of mela-
nocytes by melanin precursors is also thought to play a role in the
pathogenesis of vitiligo. Besides these, other factors such as oxida-
tive stress, nitric oxide, and the changes in the monoaminergic
system have been suggested.10e12 Vitiligo usually develops in
childhood or young adulthood.13e16 Approximately 50% of thosex: 7616913911, Kerman, Iran.
h).
iwanese Dermatological Associatiowith vitiligo acquire the disease before the age of 20 years, and the
incidence decreases with increasing age.17
Apart from one study on 182 patients from India, to the best of
our knowledge there are no published data on the worldwide
epidemiology of late-onset vitiligo.18 However, that study was just
a descriptive study on late-onset vitiligo and no comparisons were
made between late- and early-onset vitiligo.
Considering the extent of disease burden and the paucity of
published information on this subject, the aim of the present study
was to analyze and report the epidemiological and clinical features
of patients with late-onset vitiligo and compare them to patients
with early-onset vitiligo.
Materials and methods
In this cross-sectional study, which was performed from March
2003 to May 2006, 45,910 new patients were referred to the
Dermatological Outpatient Department of Afzalipour Hospital, the
main referral center of Kerman province in Iran. Of these new
patients, 825 patients (1.8%) were diagnosed with vitiligo based on
a clinical examination. This study was approved by the review
board and ethics committee of Kerman University of Medicaln. Published by Elsevier Taiwan LLC. All rights reserved.
Table 2 Age of at onset of vitiligo and sex distribution of patients with late-onset
vitiligo.
Age group (y) Female Male Total (%)
50e55 15 16 31 (57.4)
56e60 6 4 10 (18.5)
61e65 4 2 6 (11)
66e70 1 4 5 (9.3)
71e75 0 1 1 (1.9)
 76 0 1 1 (1.9)
Total 26 28 54 (100)
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pating patient. Skin biopsies, histopathological studies (Fontana-
Masson stain), and Wood’s lamp examination were performed to
diagnose uncertain cases and exclude other diagnoses such as
pityriasis alba, guttate hypomelanosis, or postinﬂammatory hypo-
pigmentation. Tinea versicolor was excluded mostly by Wood’s
lamp examination and, if necessary, by the examination of skin
scrapings. Questionnaires were completed by an expert dermatol-
ogist to determine sex, age, duration of disease, clinical patterns,
age of onset, Koebner phenomenon, leukotrichia, initial site of
disease, family history, mucosal involvement, halo nevus, and
associated diseases. Associated diseases were determined by
reviewing each patient’s medical history and performing a physical
examination and, in uncertain cases, by performing related labo-
ratory tests. The vitiligo patients were divided into late- and early-
onset groups according to age of vitiligo onset. Those with vitiligo
onset after 50 years of age were categorized as late-onset vitiligo.18
Family history of vitiligo was obtained by determining the
incidence of vitiligo in each patient’s immediate family members
through fourth-degree relatives. Patients were broadly categorized
as having segmental or nonsegmental vitiligo. Segmental vitiligo
was considered when there was evidence of dermatomal distri-
bution. Nonsegmental vitiligo was deﬁned as all other types of
vitiligo, such as localized, generalized, mucosal, acrofacial, and
universal. Localized vitiligo was deﬁned as discrete patches that
were conﬁned to one particular area of the bodywithout segmental
distribution.
Statistical analysis
Data are presented as the means and standard deviations (SD) of
the quantitative variables and absolute and relative frequencies of
the categorical variables. In order to compare the two groups, the
Student t test (for continuous data) and Chi-square test (for cate-
gorical data) were used and, if necessary, the Fisher exact test was
used. All statistical analyses were performed using SPSS (version
15; Chicago, IL, USA). A p value < 0.05 was considered statistically
signiﬁcant.
Results
Of the 45,910 new patients who were referred to the dermatolog-
ical outpatient department over the period of 3 years, 832 received
a primary diagnosis of vitiligo. Seven cases suspected of being
vitiligo were excluded following skin biopsy and Wood’s lamp
testing: four were diagnosed with pityriasis alba, two with post-
inﬂammatory hypopigmentation, and one with idiopathic guttate
hypomelanosis. In the end, 825 cases were diagnosed with vitiligo
(1.8%). Of these patients with vitiligo, 54 (6.5%) patients were
diagnosed with late-onset vitiligo (> 50 years of age) and 771
(93.5%) were diagnosed with early-onset vitiligo. The clinicalTable 1 Clinical features of vitiligo in the late- and early-onset groups.
Clinical features Early onset
n¼ 771 (%)
Late onset
n¼ 54 (%)
p
Sex
Female 493 (63.9)* 26 (48.1) 0.02
Male 278 (36.1) 28 (51.9)
Family history 311 (40.4) 15 (27.8) 0.068
Koebner phenomenon 500 (64.9) 43 (79.6) 0.02
Leukotrichia 406 (52.7) 42 (77.8) < 0.001
Associated mucosal involvement 362 (47) 32 (59.3) 0.08
Associated disease 178 (23.1) 10 (18.5) 0.43
* %.features of late- and early-onset vitiligo are shown in Table 1. Of the
54 patients with late-onset vitiligo, 26 (48.1%) were female and 28
(51.9%) were male. Of those with early-onset vitiligo, 63.9% were
female and 36.1% were male (p¼ 0.02).
Disease duration at the time of diagnosis ranged from 1month to
20 years in the late-onset group and 2 months to 18 years in the
early-onset group. The age distribution of the patients in late-onset
group is shown in Table 2. Forty-one (76%) patients developed viti-
ligo between the ages of 50e60 years and the rest of these patients
developed vitiligo after 60 years of age. The mean age of disease
onset was 56.57 7.05 years, and themean age of the patients at the
time of referral was 60.02 8.17 years in the late-onset group. The
mean age of the patients in the early-onset group at the time of
referral was 24.214.04 years (1e80 years). Positive family history
was veriﬁed in 27.8% and 40.4% of the late- and early-onset patients,
respectively, which was not statistically signiﬁcant.
Themost common ﬁrst site of involvement was the limbs (upper
and lower), which was observed in 31 patients (57.4%), followed by
the head and neck in 17 patients (31.5%) and the trunk in six (11.1%)
patients with late-onset vitiligo. In patients with early-onset viti-
ligo, the limbs were the most common (50%) ﬁrst site of involve-
ment followed by the head and neck (33%) and trunk (17%).
The clinical types of vitiligo that were observed in our patients are
shown in Table 3. Generalized vitiligo (vitiligo vulgaris) was the
most common type in both groups. The universal (p¼ 0.01) and
localized (p¼ 0.048) types were more common in the late-onset
group than the early-onset group. Koebner phenomenon (isomor-
phic) was observed in 43 (79.6%) late- and 500 (64.9%) early-onset
vitiligo patients (p¼ 0.02). Leukotrichia was present in vitiligo
lesions involving hair-bearing areas in 77.8% of late-onset vitiligo
patients and in 52.7% of early-onset vitiligo patients (p< 0.001).
The pure mucosal type of vitiligo was not detected, but associated
mucosal involvement with other clinical variants (generalized or
acrofacial; Figure 1) was observed in 59.3% and 47% of the late- and
early-onset vitiligo patients, respectively (p¼ 0.08).
Of the 28 patients with mucosal involvement in the late-onset
group, genital mucosal involvement was noted in three patients
and oral mucosal involvement was noted in 25 patients. Halo nevus
was present in one patient (1.9%) with late-onset vitiligo and 10
patients (1.3%) with early-onset vitiligo. Associated disorders were
observed in 10 patients (18.5%) with late-onset vitiligo and in 178
patients (23.1%) with early-onset vitiligo. Diabetes mellitus was
present in six (11.1%) patients, hypothyroidism in one (1.9%),Table 3 Clinical types of vitiligo in the late- and early-onset groups.
Distribution Early onset n¼ 771 (%) Late onset n¼ 54 (%) p
Segmental 58 (7.8) 2 (3.7) 0.26
Generalized 348 (47) 32 (59.3) 0.082
Localized 184 (24.9) 7 (13) 0.048
Acrofacial 146 (19.7) 11 (20.4) 0.99
Universal 4 (0.5) 2 (3.7) 0.01
Total 740 54
Figure 1 Acrofacial vitiligo.
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patient with late-onset vitiligo. Among the early-onset vitiligo
patients, diabetes mellitus was present in 100 patients (13%),
hypothyroidism in 20 (2.6%), alopecia areata in 40 (5.2%), and lichen
planus in 18 (2.3%). There was no statistically signiﬁcant difference
between early- and late-onset vitiligo in terms of the frequencies of
the associated disorders.
Discussion
There are few studies on the epidemiology of vitiligo, and only one
study18 has been published on late-onset vitiligo. Vitiligo is the
most common depigmentation disease and affects 1e2% of the
population.19 In most cases, vitiligo develops early in life, and
different ages of onset have been reported in various studies. Some
studies have reported mean ages of onset for vitiligo that vary
between 4e8 years14e17 and 4e12 years of age.15e20 Of 825 new
cases of vitiligo that were included in the present study, 54 patients
(6.5%) claimed onset occurred after 50 years of age.
The most common clinical type of late-onset vitiligo was vitiligo
vulgaris (generalized type) followed by acrofacial, localized (focal),
universal, and segmental. In their study on 182 patients with late-
onset vitiligo, Dogra et al reported vitiligo vulgaris as the most
common clinical type followed by focal, segmental, acrofacial, pure
mucosal, and universal.18 The clinical features reported in the study
by Dogra et al are compared with our study in Table 4. As in theTable 4 Comparison of the clinical features of the present study and the study by
Dogra et al.
Clinical features Present study Dogra et al
Mean age of onset (y) 56.57 7.05 55 2.3
Sex
Female 48.1a 52.2a
Male 51.9a 47.8a
Family history 27.8 15.9
Koebner Phenomenon 79.6 14.8
Leukotrichia 77.8 47.3
Associated disorder 18.5 21.4
Clinical types
Generalized 59.3 83.5
Acrofacial 20.4 3.8
Localized 13 5.5
Segmental 3.7 4.4
Universal 3.7 0.5
Pure mucosa 0 2.2
a Indicates percentage.study by Dogra et al, the study by Liu et al also reported vitiligo
vulgaris as the most common clinical type.6,18 Focal vitiligo was the
secondmost commonpresentation of vitiligo among the patients in
the study by Dogra et al, but the acrofacial type was the second
most common type in the present study among patients with late-
onset vitiligo. The segmental and universal types were the least
common types seen in our study. Segmental vitiligo generally
affects children and young patients and is a signiﬁcantly large
subgroup (19.4e32.5%) within cases of childhood vitiligo.13,14,20,21
In the study by Dogra et al, the pure mucosal and universal types
were the least common. The pure mucosal type of vitiligo was not
observed in our patients, but mucosal involvement in association
with other clinical variants was seen in our patients with late-onset
vitiligo and was signiﬁcantly more common than in the early-onset
group. It is worth noting that no comparisons were made with an
early-onset group in the study by Dogra et al. Differences in the
proportions of clinical types of vitiligo between different studies
may be due to racial or genetic factors unique to those areas and
populations; some hitherto unidentiﬁed environmental factors
may also play a role.
The limbs were the most common ﬁrst site of involvement in
our patients. However in the study by Dogra et al, the head and
neck was the most common early site of involvement. A higher
degree of positive family history (immediate family members
through fourth-degree relatives) was present in our patients with
late-onset vitiligo (27.8%) compared with the late-onset vitiligo
patients reported by Dogra et al.18 However, in our study, there was
no statistically signiﬁcant differences in terms of family history
between the late- and early-onset groups. This difference with the
study by Dogra et al may be due to patient selection (ﬁrst through
second-degree relatives and ﬁrst through fourth-degree relatives
were examined in the study by Dogra et al and our study, respec-
tively), the number of enrolled patients, and racial and genetic
factors.
Leukotrichiawas observed in 77.8% of late-onset vitiligo patients;
the most common variant was vitiligo vulgaris (55.5%), and this
incidence was signiﬁcantly higher than that observed in the early-
onset group of our study. The rate of leukotrichia was also higher
than that observed in the study by Dogra et al: 77.8% compared with
47.3%, respectively. More patients with late-onset vitiligo presented
with Koebner phenomenon (79.6%) compared with the study by
Dogra.15,19 Racial, genetic, solar, and other unknown environmental
factors may be involved in the higher incidence of leukotrichia and
Koebner phenomenon observed in our study.
Vitiligo was associated with other autoimmune diseases in
18.5% of the subjects with late-onset and 23.1% of patients with
early-onset, which was not statistically signiﬁcant. In the study by
Dogra et al on late-onset vitiligo, autoimmune disorders were
present in 21.4% of patients. Diabetes mellitus was present in 11.0%
of our late-onset patients and in 14.8%18 of the patients reported by
Dogra et al. The prevalence of diabetes was higher than what has
been reported (8.7% in 2007) 22 in the Iranian population and may
require further study. Hypothyroidism was present in 1.8% of our
late-onset group and 8.2% of the patients in the study by Dogra et al,
but the incidence of thyroid disease in vitiligo patients has been
reported to vary from 0.6e30% in other studies.1,5,6,10,19,23 Although
the prevalence of hypothyroidism has not been extensively inves-
tigated, the prevalence of hypothyroidism in a nongoitrous pop-
ulation was reported to be 6.4% in one study, which is higher than
the ﬁndings of this study.24 This difference may be due to the small
number of patients, race, criteria used to screen our patients, and
other unknown factors.
The main limitation of this study is that none of the patients
underwent laboratory testing to detect associated diseases and we
only relied on patient medical histories and physical examinations
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those with uncertain medical histories and physical examinations.
In addition, we did not perform follow-up examinations on our
patients, which should be emphasized in future studies.
Conclusion
Here, we present our data on the epidemiological and clinical
aspects of late-onset vitiligo (deﬁned as disease onset after 50 years
of age) in comparison with early-onset vitiligo. Late-onset vitiligo
was rare in this study, only presenting in 6.5% of vitiligo patients.
The peak age of disease onset was between 50e60 years of age. The
female-to-male ratio was signiﬁcantly higher among patients with
early-onset vitiligo than late-onset.
There was also a higher frequency of Koebner phenomenon,
leukotrichia, and mucosal involvement among patients with late-
onset vitiligo than early-onset. Although the universal type was
signiﬁcantly more common among patients with late-onset vitiligo
than those with early-onset vitiligo, the number of patients with
this type of vitiligo was small in both groups, making it difﬁcult to
come in to a clear conclusion about its signiﬁcance.
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